MPTH-06. 1p/19q CO-DELETION STATUS PREDICTS SURVIVAL OUTCOMES IN NRG ONCOLOGY/RTOG 9802: A PHASE III TRIAL OF RT VS RT + PCV IN HIGH RISK LOW-GRADE GLIOMAS Article

Bell, Erica H, Zhang, Peixin, Shaw, Edward G et al. (2016). MPTH-06. 1p/19q CO-DELETION STATUS PREDICTS SURVIVAL OUTCOMES IN NRG ONCOLOGY/RTOG 9802: A PHASE III TRIAL OF RT VS RT + PCV IN HIGH RISK LOW-GRADE GLIOMAS . NEURO-ONCOLOGY, 18(suppl_6), vi106-vi106. 10.1093/neuonc/now212.444

cited authors

  • Bell, Erica H; Zhang, Peixin; Shaw, Edward G; Buckner, Jan C; Barger, Geoffrey R; Coons, Stephen W; Bullard, Dennis E; Mehta, Minesh P; Gilbert, Mark R; Brown, Paul D; Stelzer, Keith J; McElroy, Joseph P; Fleming, Jessica; Chakraborty, Arup; Becker, Aline Paixao; Aldape, Kenneth D; Brachman, David G; Murtha, Albert D; Schultz, Christopher J; Johnson, David; Gertler, Stanley Z; Laack, Nadia N; Werner-Wasik, Maria; Crocker, Ian R; Chakravarti, Arnab

authors

publication date

  • November 1, 2016

published in

keywords

  • 32 Biomedical and Clinical Sciences
  • 3211 Oncology and Carcinogenesis
  • 4.2 Evaluation of markers and technologies
  • Brain Cancer
  • Brain Disorders
  • Cancer
  • Clinical Research
  • Neurosciences
  • Precision Medicine
  • Radiation Oncology
  • Rare Diseases

Digital Object Identifier (DOI)

publisher

  • Oxford University Press (OUP)

start page

  • vi106

end page

  • vi106

volume

  • 18

issue

  • suppl_6